6 results
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
tuberculosis (LTBI) Pathophysiology ... drug use • Silicosis ... infection • Mostly ... (Anorexia) • Night ... TB #Diagnosis #Management
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... are contacts of infectious ... 1: Choose one later-generation ... Tuberculosis #MDRTB #management ... antimicrobials #regimens #pharmacology
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
tuberculosis (LTBI) Pathophysiology ... drug use • Silicosis ... infection • Mostly ... (Anorexia) • Night ... TB #Diagnosis #Management
IDSA Recommendations for Treating Treponema pallidum Infections (Syphilis) to Prevent Disease in HIV-AIDS
Early Stage (Primary, Secondary,
IDSA Recommendations ... 1 dose (BII) Late-Latent ... 28 days (BIII) Late-Stage ... Treponema #pallidum #IDSA ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
IDSA Recommendations ... intraocular levels of drug ... Cytomegalovirus #CMV #IDSA ... Prevention #Treatment #management ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
IDSA Recommendations ... for active or latent ... Tuberculosis #TB #IDSA ... Prevention #Treatment #management ... #HIVAIDS #pharmacology